Listen to ASX-listed Imugene MD, Leslie Chong talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s new worldwide license to develop and commercialise an innovative treatment for solid cancerous tumours developed by a renowned US cancer research centre.

<p>Listen to ASX-listed Imugene MD, Leslie Chong talk to Matt Birney on the 6PR Bulls N&rsquo; Bears Report about the company&rsquo;s new worldwide license to develop and commercialise an innovative treatment for solid cancerous tumours developed by a renowned US cancer research centre.</p>

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

<p>Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.</p>

Advertisement